In addition, in January 2025, Medicare announced it will include semaglutide products (Ozempic, Rybelsus, and Wegovy) in its second round of drug price negotiations, treating all three brands as a single drug due to their shared active ingredient.28 With negotiated prices set to take effect in 2027, this could significantly reduce costs for Medicare beneficiaries
Though no direct evidence shows caffeine interfering with semaglutide, both affect blood sugar and digestion, necessitating careful monitoring
This process proves particularly valuable for tendon injuries, ligament damage, and muscle strainconditions notoriously slow to heal through conventional treatment alone
Studies show significant weight regain after discontinuing either medication, typically recovering 50-70% of lost weight within 12 months
Understanding how these medications work individually provides essential context for evaluating their combined use and any potential interactions that may arise when taken together